Viridian’s Drug Cuts Thyroid Eye Disease Symptoms in Late-stage Study

by Medscape • 2024/09/10 • 0 Comments

Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage...
Reuters Health Information

← Viridian Therapeutics Announces Positive Topline Results from Veligrotug (VRDN-001) Phase 3 THRIVE Clinical Trial in Patients with Active Thyroid Eye Disease

Gene Therapy Shown to Improve Vision in Congenital Blindness →

Post navigation